Physician

John Gerard Devlin, M.D.

According to 2025 Medicare claims, John Devlin, M.D. (NPI: 1073728663) practices hematology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (NPI: 1841226099; TIN: 23-1714249) and primary practice location at 19010-3200. Devlin is affiliated with the Aledade 101 Regional MSSP (ACO ID: A5216), participating under the MSSP model.

Devlin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 452 traditional Medicare patients, billed 324,235 HCPCS/CPT codes, and received $4,726,505 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,149 prescription claims across 219 beneficiaries totaling $3,063,320 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 36 claims. Open Payments data shows 235 records totaling $4,991. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,096,278 to $4,726,505. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $539,953 to $3,063,320. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,995 to $1,683.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	413	173,363	$2,096,278
2016	428	220,370	$2,487,740
2017	395	281,759	$3,154,628
2018	411	310,209	$4,050,980
2019	424	242,074	$2,778,090
2020	404	225,282	$3,225,099
2021	425	233,485	$3,216,303
2022	429	298,331	$3,520,175
2023	357	271,090	$3,479,492
2024	452	324,235	$4,726,505

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	143	836	$539,953
2016	151	820	$718,849
2017	140	822	$817,586
2018	166	971	$1,046,835
2019	170	1,086	$2,030,087
2020	169	1,061	$1,940,736
2021	167	988	$2,033,514
2022	156	983	$1,799,000
2023	174	995	$2,258,144
2024	219	1,149	$3,063,320

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	117	$31,317
2016	N/R	152	$31,470
2017	N/R	13	$245
2018	N/R	N/R	N/R
2019	N/R	127	$41,295
2020	N/R	69	$1,988
2021	N/R	30	$1,732
2022	N/R	N/R	N/R
2023	N/R	36	$1,553
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	105	135	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	340	944	$98
96375	Injection of additional new drug or substance into vein	73	2,482	$12
96372	Injection of drug or substance under skin or into muscle	91	689	$11
36415	Insertion of needle into vein for collection of blood sample	114	1,048	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	25	700	$405,516
Verzenio	Abemaciclib	26	728	$401,973
Revlimid	Lenalidomide	14	392	$277,325
Brukinsa	Zanubrutinib	18	540	$262,874
Tagrisso	Osimertinib Mesylate	14	420	$232,033

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	235	$4,991	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Gerard Devlin, M.D.?

Tedicare shows public-source Medicare data for John Gerard Devlin, M.D. (NPI 1073728663), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Gerard Devlin, M.D. have ACO affiliation data?

John Gerard Devlin, M.D. is shown with ACO affiliation data for Aledade 101 Regional MSSP (MSSP, ACO ID A5216).

What billing organization is linked to John Gerard Devlin, M.D.?

John Gerard Devlin, M.D. is linked to BRYN MAWR MEDICAL SPECIALISTS ASSOCIATION (billing NPI 1841226099) in the available physician profile data.

Does John Gerard Devlin, M.D. have Open Payments data?

John Gerard Devlin, M.D. has 235 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.